Myogenic tone as a therapeutic target for ischemic stroke

Current Vascular Pharmacology

Volumn 12, Issue 6, 2014, Pages 788-800

  Palomares, Sara M ^a   Cipolla, Marilyn J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Cerebral blow flow; Circulating factors; Ischemic stroke; Middle cerebral arteries; Myogenic response; Parenchymal arterioles

Indexed keywords

ALTEPLASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; F ACTIN; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; MIFEPRISTONE; PEROXYNITRITE; PROTEIN KINASE C; TRANSIENT RECEPTOR POTENTIAL CHANNEL; VOLTAGE GATED CALCIUM CHANNEL; NITRIC OXIDE; VASODILATOR AGENT;

ACTIN POLYMERIZATION; ARTICLE; AUTOREGULATION; BLOOD VESSEL REACTIVITY; BRAIN ISCHEMIA; BRAIN VASCULAR RESISTANCE; COLLATERAL CIRCULATION; HUMAN; INFLAMMATION; MEMBRANE DEPOLARIZATION; MIDDLE CEREBRAL ARTERY; MUSCLE TONE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; ANIMAL; BRAIN CIRCULATION; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HOMEOSTASIS; METABOLISM; PHYSIOLOGY; STROKE; TRENDS; VASCULAR SMOOTH MUSCLE;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DRUG DELIVERY SYSTEMS; ENDOTHELIN-1; HOMEOSTASIS; HUMANS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; STROKE; VASODILATOR AGENTS;

EID: 84923231084     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/15701611113116660155     Document Type: Article

References (153)

1. Nishigaya K, Yoshida Y, Sasuga M, Nukui H, Ooneda G. Effect of recirculation on exacerbation of ischemic vascular lesions in rat brain. Stroke 1991; 22: 635-42.
2. Cipolla MJ, McCall AL, Lessov N, Porter JM. Reperfusion decreases myogenic reactivity and alters middle cerebral artery function after focal cerebral ischemia in rats. Stroke 1997; 28: 176-80.
3. Kagstrom E, Smith ML, Siesjo BK. Local cerebral blood flow in the recovery period following complete cerebral ischemia in the rat. J Cereb Blood Flow Metab 1983; 3: 170-82.
4. Takahashi A, Park HK, Melgar MA, et al. Cerebral cortex blood flow and vascular smooth muscle contractility in a rat model of ischemia: a correlative laser Doppler flowmetric and scanning electron microscopic study. Acta Neuropathol 1997; 93: 354-68.
5. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J Neurosurg 1992; 77: 337-54.
6. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 1992; 77: 169-84.
7. Tasdemiroglu E, Macfarlane R, Wei EP, Kontos HA, Moskowitz MA. Pial vessel caliber and cerebral blood flow become dissociated during ischemia-reperfusion in cats. Am J Physiol 1992; 263: H533-6.
8. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990; 2: 161-92.
9. Phillips SJ, Whisnant JP. Hypertension and the brain. The National High Blood Pressure Education Program. Arch Intern Med 1992; 152: 938-45.
10. Faraci FM, Baumbach GL, Heistad DD. Myogenic mechanisms in the cerebral circulation. J Hypertens Suppl 1989; 7: S61-4; discussion S5.
11. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 1990; 66: 8-17.
12. Shapiro HM, Stromberg DD, Lee DR, Wiederhielm CA. Dynamic pressures in the pial arterial microcirculation. Am J Physiol 1971; 221: 279-83.
13. Mellander S. Functional aspects of myogenic vascular control. J Hypertens Suppl 1989; 7: S21-30; discussion S1.
14. Johansson B. Myogenic tone and reactivity: definitions based on muscle physiology. J Hypertens Suppl 1989; 7: S5-8; discussion S9.
15. Nishimura N, Schaffer CB, Friedman B, Lyden PD, Kleinfeld D. Penetrating arterioles are a bottleneck in the perfusion of neocortex. Proc Natl Acad Sci USA 2007; 104: 365-70.
16. Kulik T, Kusano Y, Aronhime S, Sandler AL, Winn HR. Regulation of cerebral vasculature in normal and ischemic brain. Neuropharmacology 2008; 55: 281-8.
17. Hossmann KA. Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol 2006; 26: 1057-83.
18. Liebeskind DS. Collateral circulation. Stroke 2003; 34: 2279-84.
19. Liebeskind DS. Understanding blood flow: the other side of an acute arterial occlusion. Int J Stroke 2007; 2: 118-20.
20. Santa N, Kitazono T, Ago T, et al. ATP-sensitive potassium channels mediate dilatation of basilar artery in response to intracellular acidification in vivo. Stroke 2003; 34: 1276-80.
21. Winn HR, Rubio R, Berne RM. Brain adenosine production in the rat during 60 seconds of ischemia. Circ Res 1979; 45: 486-92.
22. Girouard H, Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 2006; 100: 328-35.
23. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36: 557-65.
24. Hakim AM. The cerebral ischemic penumbra. Can J Neurol Sci 1987; 14: 557-9.
25. Hoehn-Berlage M, Norris DG, Kohno K, Mies G, Leibfritz D, Hossmann KA. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances. J Cereb Blood Flow Metab 1995; 15: 1002-11.
26. Gourley JK, Heistad DD. Characteristics of reactive hyperemia in the cerebral circulation. Am J Physiol 1984; 246: H52-8.
27. Sundt TM, Jr., Waltz AG. Cerebral ischemia and reactive hyperemia. Studies of cortical blood flow and microcirculation before, during, and after temporary occlusion of middle cerebral artery of squirrel monkeys. Circ Res 1971; 28: 426-33.
28. Hayakawa T, Waltz AG, Hansen T. Relationships among intracranial pressure, blood pressure, and superficial cerebral vasculature after experimental occlusion of one middle cerebral artery. Stroke 1977; 8: 426-32.
29. Hossmann KA. Reperfusion of the brain after global ischemia: hemodynamic disturbances. Shock 1997; 8: 95-101; discussion 2-3.
30. Leffler CW, Busija DW, Mirro R, Armstead WM, Beasley DG. Effects of ischemia on brain blood flow and oxygen consumption of newborn pigs. Am J Physiol 1989; 257: H1917-26.
31. Hauck EF, Apostel S, Hoffmann JF, Heimann A, Kempski O. Capillary flow and diameter changes during reperfusion after global cerebral ischemia studied by intravital video microscopy. J Cereb Blood Flow Metab 2004; 24: 383-91.
32. Little JR, Kerr FW, Sundt TM, Jr. Microcirculatory obstruction in focal cerebral ischemia. Relationship to neuronal alterations. Mayo Clin Proc 1975; 50: 264-70.
33. del Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991; 22: 1276-83.
34. Hallenbeck JM, Dutka AJ, Tanishima T, et al. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 1986; 17: 246-53.
35. Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 2009; 15: 1031-7.
36. Aronowski J, Strong R, Grotta JC. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab 1997; 17: 1048-56.
37. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol 1902; 28: 220-31.
38. Busija DW, Heistad DD. Factors involved in the physiological regulation of the cerebral circulation. Rev Physiol Biochem Pharmacol 1984; 101: 161-211.
39. Martinez-Lemus LA, Crow T, Davis MJ, Meininger GA. alphavbeta3-and alpha5beta1-integrin blockade inhibits myogenic constriction of skeletal muscle resistance arterioles. Am J Physiol Heart Circ Physiol 2005; 289: H322-9.
40. Kontos HA, Wei EP, Raper AJ, Rosenblum WI, Navari RM, Patterson JL, Jr. Role of tissue hypoxia in local regulation of cerebral microcirculation. Am J Physiol 1978; 234: H582-91.
41. Osol G, Brekke JF, McElroy-Yaggy K, Gokina NI. Myogenic tone, reactivity, and forced dilatation: a three-phase model of in vitro arterial myogenic behavior. Am J Physiol Heart Circ Physiol 2002; 283: H2260-7.
42. Cipolla MJ, Osol G. Vascular smooth muscle actin cytoskeleton in cerebral artery forced dilatation. Stroke 1998; 29: 1223-8.
43. Olsen TS, Larsen B, Skriver EB, Herning M, Enevoldsen E, Lassen NA. Focal cerebral hyperemia in acute stroke. Incidence, pathophysiology and clinical significance. Stroke 1981; 12: 598-607.
44. Lassen NA, Agnoli A. The upper limit of autoregulation of cerebral blood flow--on the pathogenesis of hypertensive encepholopathy. Scand J Clin Lab Invest 1972; 30: 113-6.
45. Euser AG, Cipolla MJ. Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats. Hypertension 2007; 49: 334-40.
46. Johansson B, Li CL, Olsson Y, Klatzo I. The effect of acute arterial hypertension on the blood-brain barrier to protein tracers. Acta Neuropathol 1970; 16: 117-24.
47. Cipolla MJ, Lessov N, Hammer ES, Curry AB. Threshold duration of ischemia for myogenic tone in middle cerebral arteries: effect on vascular smooth muscle actin. Stroke 2001; 32: 1658-64.
48. Cipolla MJ, Curry AB. Middle cerebral artery function after stroke: the threshold duration of reperfusion for myogenic activity. Stroke 2002; 33: 2094-9.
49. Cipolla MJ, Smith J, Kohlmeyer MM, Godfrey JA. SKCa and IKCa Channels, myogenic tone, and vasodilator responses in middle cerebral arteries and parenchymal arterioles: effect of ischemia and reperfusion. Stroke 2009; 40: 1451-7.
50. Cipolla MJ, Bullinger LV. Reactivity of brain parenchymal arterioles after ischemia and reperfusion. Microcirculation 2008; 15: 495-501.
51. Shih AY, Friedman B, Drew PJ, Tsai PS, Lyden PD, Kleinfeld D. Active dilation of penetrating arterioles restores red blood cell flux to penumbral neocortex after focal stroke. J Cereb Blood Flow Metab 2009; 29: 738-51.
52. Schubert R, Lidington D, Bolz SS. The emerging role of Ca2+ sensitivity regulation in promoting myogenic vasoconstriction. Cardiovasc Res 2008; 77: 8-18.
53. McCarron JG, Crichton CA, Langton PD, MacKenzie A, Smith GL. Myogenic contraction by modulation of voltage-dependent calcium currents in isolated rat cerebral arteries. J Physiol 1997; 498(Pt 2): 371-9.
54. Knot HJ, Nelson MT. Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 1998; 508(Pt 1): 199-209.
55. Dopico AM, Kirber MT, Singer JJ, Walsh JV, Jr. Membrane stretch directly activates large conductance Ca(2+)-activated K+ channels in mesenteric artery smooth muscle cells. Am J Hypertens 1994; 7: 82-9.
56. Kotecha N, Hill MA. Myogenic contraction in rat skeletal muscle arterioles: smooth muscle membrane potential and Ca(2+) signaling. Am J Physiol Heart Circ Physiol 2005; 289: H1326-34.
57. Hill MA, Meininger GA, Davis MJ, Laher I. Therapeutic potential of pharmacologically targeting arteriolar myogenic tone. Trends Pharmacol Sci 2009; 30: 363-74.
58. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 2002; 90: 248-50.
59. Earley S, Waldron BJ, Brayden JE. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res 2004; 95: 922-9.
60. Nelson MT, Conway MA, Knot HJ, Brayden JE. Chloride channel blockers inhibit myogenic tone in rat cerebral arteries. J Physiol 1997; 502(Pt 2): 259-64.
61. Jaggar JH, Wellman GC, Heppner TJ, et al. Ca2+ channels, ryanodine receptors and Ca(2+)-activated K+ channels: a functional unit for regulating arterial tone. Acta Physiol Scand 1998; 164: 577-87.
62. Quayle JM, McCarron JG, Brayden JE, Nelson MT. Inward rectifier K+ currents in smooth muscle cells from rat resistancesized cerebral arteries. Am J Physiol 1993; 265: C1363-70.
63. Flavahan NA, Bailey SR, Flavahan WA, Mitra S, Flavahan S. Imaging remodeling of the actin cytoskeleton in vascular smooth muscle cells after mechanosensitive arteriolar constriction. Am J Physiol Heart Circ Physiol 2005; 288: H660-9.
64. Cipolla MJ, Gokina NI, Osol G. Pressure-induced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behavior. FASEB J 2002; 16: 72-6.
65. Coulson RJ, Chesler NC, Vitullo L, Cipolla MJ. Effects of ischemia and myogenic activity on active and passive mechanical properties of rat cerebral arteries. Am J Physiol Heart Circ Physiol 2002; 283: H2268-75.
66. Banan A, Fields JZ, Zhang Y, Keshavarzian A. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol 2001; 280: G1234-46.
67. Schwartz N, Hosford M, Sandoval RM, et al. Ischemia activates actin depolymerizing factor: role in proximal tubule microvillar actin alterations. Am J Physiol 1999; 276: F544-51.
68. Bemeur C, Ste-Marie L, Montgomery J. Increased oxidative stress during hyperglycemic cerebral ischemia. Neurochem Int 2007; 50: 890-904.
69. Maneen MJ, Hannah R, Vitullo L, DeLance N, Cipolla MJ. Peroxynitrite diminishes myogenic activity and is associated with decreased vascular smooth muscle F-actin in rat posterior cerebral arteries. Stroke 2006; 37: 894-9.
70. Maneen MJ, Cipolla MJ. Peroxynitrite diminishes myogenic tone in cerebral arteries: role of nitrotyrosine and F-actin. Am J Physiol Heart Circ Physiol 2007; 292: H1042-50.
71. Hsu SS, Meno JR, Gronka R, Kushmerick M, Winn HR. Moderate hyperglycemia affects ischemic brain ATP levels but not intracellular pH. Am J Physiol 1994; 266: H258-62.
72. Gisselsson LL, Matus A, Wieloch T. Actin redistribution underlies the sparing effect of mild hypothermia on dendritic spine morphology after in vitro ischemia. J Cereb Blood Flow Metab 2005; 25: 1346-55.
73. Miyata N, Seki T, Tanaka Y, et al. Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke. J Pharmacol Exp Ther 2005; 314: 77-85.
74. Marrelli SP, Johnson TD, Khorovets A, Childres WF, Bryan RM, Jr. Altered function of inward rectifier potassium channels in cerebrovascular smooth muscle after ischemia/reperfusion. Stroke 1998; 29: 1469-74.
75. Bastide M, Bordet R, Pu Q, Robin E, Puisieux F, Dupuis B. Relationship between inward rectifier potassium current impairment and brain injury after cerebral ischemia/reperfusion. J Cereb Blood Flow Metab 1999; 19: 1309-15.
76. Kawamura S, Shirasawa M, Fukasawa H, Yasui N. Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats. Stroke 1991; 22: 51-5.
77. Shiino A, Matsuda M, Susumu T, Handa J. Effects of the calcium antagonist nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats. Surg Neurol 1991; 35: 105-10.
78. Hill MA, Davis MJ, Meininger GA, Potocnik SJ, Murphy TV. Arteriolar myogenic signalling mechanisms: Implications for local vascular function. Clin Hemorheol Microcirc 2006; 34: 67-79.
79. Osol G, Laher I, Cipolla M. Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 1991; 68: 359-67.
80. Lagaud G, Gaudreault N, Moore ED, Van Breemen C, Laher I. Pressure-dependent myogenic constriction of cerebral arteries occurs independently of voltage-dependent activation. Am J Physiol Heart Circ Physiol 2002; 283: H2187-95.
81. Hori M, Karaki H. Regulatory mechanisms of calcium sensitization of contractile elements in smooth muscle. Life Sci 1998; 62: 1629-33.
82. Satoh S, Utsunomiya T, Tsurui K, et al. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage. Life Sci 2001; 69: 1441-53.
83. Bright R, Mochly-Rosen D. The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke 2005; 36: 2781-90.
84. Laher I, Zhang JH. Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab 2001; 21: 887-906.
85. Maczewski M, Beresewicz A. The role of endothelin, protein kinase C and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts. J Mol Cell Cardiol 2000; 32: 297-310.
86. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 1998; 78: 53-97.
87. Faraci FM, Brian JE, Jr. Nitric oxide and the cerebral circulation. Stroke 1994; 25: 692-703.
88. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
89. Tayeh MA, Marletta MA. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J Biol Chem 1989; 264: 19654-8.
90. Bauer PM, Fulton D, Boo YC, et al. Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J Biol Chem 2003; 278: 14841-9.
91. Dalkara T, Moskowitz MA. The complex role of nitric oxide in the pathophysiology of focal cerebral ischemia. Brain Pathol 1994; 4: 49-57.
92. Lo EH, Hara H, Rogowska J, et al. Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke 1996; 27: 1381-5.
93. Huang Z, Huang PL, Ma J, et al. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-Larginine. J Cereb Blood Flow Metab 1996; 16: 981-7.
94. Panahian N, Yoshida T, Huang PL, et al. Attenuated hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase. Neuroscience 1996; 72: 343-54.
95. Zhang ZG, Chopp M, Bailey F, Malinski T. Nitric oxide changes in the rat brain after transient middle cerebral artery occlusion. J Neurol Sci 1995; 128: 22-7.
96. Iadecola C. Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link? Trends Neurosci 1993; 16: 206-14.
97. Kanwar S, Kubes P. Nitric oxide is an antiadhesive molecule for leukocytes. New Horiz 1995; 3: 93-104.
98. Veltkamp R, Rajapakse N, Robins G, Puskar M, Shimizu K, Busija D. Transient focal ischemia increases endothelial nitric oxide synthase in cerebral blood vessels. Stroke 2002; 33: 2704-10.
99. Cipolla MJ, Lessov N, Clark WM, Haley EC, Jr. Postischemic attenuation of cerebral artery reactivity is increased in the presence of tissue plasminogen activator. Stroke 2000; 31: 940-5.
100. Marrelli SP, Khorovets A, Johnson TD, Childres WF, Bryan RM, Jr. P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion. Am J Physiol 1999; 276: H33-41.
101. Mayhan WG, Amundsen SM, Faraci FM, Heistad DD. Responses of cerebral arteries after ischemia and reperfusion in cats. Am J Physiol 1988; 255: H879-84.
102. Rosenblum WI. Selective impairment of response to acetylcholine after ischemia/reperfusion in mice. Stroke 1997; 28: 448-51; discussion 51-2.
103. Nelson CW, Wei EP, Povlishock JT, Kontos HA, Moskowitz MA. Oxygen radicals in cerebral ischemia. Am J Physiol 1992; 263: H1356-62.
104. Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 1998; 273: 25804-8.
105. Heinzel B, John M, Klatt P, Bohme E, Mayer B. Ca2+/calmodulindependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 1992; 281 (Pt 3): 627-30.
106. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 1992; 267: 24173-6.
107. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 2001; 281: H981-6.
108. Beckman JS, Chen J, Crow JP, Ye YZ. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain Res 1994; 103: 371-80.
109. Milstien S, Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 1999; 263: 681-4.
110. Dudzinski DM, Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res 2007; 75: 247-60.
111. Hashiguchi A, Yano S, Morioka M, Hamada J, Kochi M, Fukunaga K. Dephosphorylation of eNOS on Thr495 after transient forebrain ischemia in gerbil hippocampus. Brain Res Mol Brain Res 2005; 133: 317-9.
112. Chen CA, Druhan LJ, Varadharaj S, Chen YR, Zweier JL. Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. J Biol Chem 2008; 283: 27038-47.
113. Marrelli SP, Eckmann MS, Hunte MS. Role of endothelial intermediate conductance KCa channels in cerebral EDHFmediated dilations. Am J Physiol Heart Circ Physiol 2003; 285: H1590-9.
114. McNeish AJ, Sandow SL, Neylon CB, Chen MX, Dora KA, Garland CJ. Evidence for involvement of both IKCa and SKCa channels in hyperpolarizing responses of the rat middle cerebral artery. Stroke 2006; 37: 1277-82.
115. Dora KA, Gallagher NT, McNeish A, Garland CJ. Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries. Circ Res 2008; 102: 1247-55.
116. Zygmunt PM, Hogestatt ED. Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br J Pharmacol 1996; 117: 1600-6.
117. Si H, Heyken WT, Wolfle SE, et al. Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 2006; 99: 537-44.
118. You J, Johnson TD, Marrelli SP, Bryan RM, Jr. Functional heterogeneity of endothelial P2 purinoceptors in the cerebrovascular tree of the rat. Am J Physiol 1999; 277: H893-900.
119. Ledoux J, Werner ME, Brayden JE, Nelson MT. Calcium-activated potassium channels and the regulation of vascular tone. Physiology (Bethesda) 2006; 21: 69-78.
120. Marrelli SP. Altered endothelial Ca2+ regulation after ischemia/reperfusion produces potentiated endothelium-derived hyperpolarizing factor-mediated dilations. Stroke 2002; 33: 2285-91.
121. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46: 325-415.
122. Ehrenreich H, Schilling L. New developments in the understanding of cerebral vasoregulation and vasospasm: the endothelin-nitric oxide network. Cleve Clin J Med 1995; 62: 105-16.
123. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke 1992; 23: 1014-6.
124. Barone FC, Globus MY, Price WJ, et al. Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab 1994; 14: 337-42.
125. Bian LG, Zhang TX, Zhao WG, Shen JK, Yang GY. Increased endothelin-1 in the rabbit model of middle cerebral artery occlusion. Neurosci Lett 1994; 174: 47-50.
126. D'Orleans-Juste P, Claing A, Warner TD, Yano M, Telemaque S. Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat. Br J Pharmacol 1993; 110: 687-92.
127. Barone FC, Willette RN, Yue TL, Feurestein G. Therapeutic effects of endothelin receptor antagonists in stroke. Neurol Res 1995; 17: 259-64.
128. Dawson DA, Sugano H, McCarron RM, Hallenbeck JM, Spatz M. Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia. Neurochem Res 1999; 24: 1499-505.
129. Matsuo Y, Mihara S, Ninomiya M, Fujimoto M. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats. Stroke 2001; 32: 2143-8.
130. Leung JW, Chung SS, Chung SK. Endothelial endothelin-1 overexpression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion. Brain Res 2009; 1266: 121-9.
131. Kawai N, McCarron RM, Spatz M. Endothelins stimulate sodium uptake into rat brain capillary endothelial cells through endothelin A-like receptors. Neurosci Lett 1995; 190: 85-8.
132. Stanimirovic DB, Bertrand N, McCarron R, Uematsu S, Spatz M. Arachidonic acid release and permeability changes induced by endothelins in human cerebromicrovascular endothelium. Acta Neurochir Suppl (Wien) 1994; 60: 71-5.
133. Kleindorfer D, Xu Y, Moomaw CJ, Khatri P, Adeoye O, Hornung R. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke 2009; 40: 3580-4.
134. Koudstaal PJ, Stibbe J, Vermeulen M. Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. BMJ 1988; 297: 1571-4.
135. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006; 26: 654-65.
136. Ahmad M, Graham SH. Inflammation After Stroke: Mechanisms and Therapeutic Approaches. Transl Stroke Res 2010; 1: 74-84.
137. Fassbender K, Rossol S, Kammer T, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994; 122: 135-9.
138. Zaremba J, Skrobanski P, Losy J. Tumour necrosis factor-alpha is increased in the cerebrospinal fluid and serum of ischaemic stroke patients and correlates with the volume of evolving brain infarct. Biomed Pharmacother 2001; 55: 258-63.
139. Rodriguez-Gonzalez R, Sobrino T, Rodriguez-Yanez M, et al. Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke. J Transl Med 2011; 9: 58.
140. Iversen PO, Nicolaysen A, Kvernebo K, Benestad HB, Nicolaysen G. Human cytokines modulate arterial vascular tone via endothelial receptors. Pflugers Arch 1999; 439: 93-100.
141. van der Poll T, Lowry SF. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 1995; 3: 1-12.
142. Vila E, Salaices M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol 2005; 288: H1016-21.
143. Tureen J. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide. J Clin Invest 1995; 95: 1086-91.
144. Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med 2002; 8: 1363-8.
145. Cipolla MJ, Sweet JG, Gardner-Morse I. Effect of circulating factors on cerebral artery function during hyperglycemic stroke. FASEB J 2011; 25:10246.
146. Pretnar-Oblak J, Sabovic M, Pogacnik T, Sebestjen M, Zaletel M. Flow-mediated dilatation and intima-media thickness in patients with lacunar infarctions. Acta Neurol Scand 2006; 113: 273-7.
147. Pretnar-Oblak J, Sabovic M, Sebestjen M, Pogacnik T, Zaletel M. Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions. Stroke 2006; 37: 2540-5.
148. Pretnar-Oblak J, Zaletel M, Zvan B, Sabovic M, Pogacnik T. Cerebrovascular reactivity to L-arginine in patients with lacunar infarctions. Cerebrovasc Dis 2006; 21: 180-6.
149. Williams LS, Rotich J, Qi R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59: 67-71.
150. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
151. Mandarino LJ, Finlayson J, Hassell JR. High glucose downregulates glucose transport activity in retinal capillary pericytes but not endothelial cells. Invest Ophthalmol Vis Sci 1994; 35: 964-72.
152. Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab 2007; 27: 435-51.
153. Kunz A, Iadecola C. Cerebral vascular dysregulation in the ischemic brain. Handb Clin Neurol 2009; 92: 283-305.